Mesoblast (MEOBF) Long-Term Investments (2018 - 2025)
Mesoblast's (MEOBF) quarterly Long-Term Investments came in at $1.6 million in Q4 2025, up 28.39% year-over-year from $1.2 million in Q4 2024, and up 11.74% quarter-over-quarter from $1.4 million in Q2 2025.
Analysis
Mesoblast (MEOBF) Long-Term Investments (2018 - 2025) Analysis & Trends
Mesoblast has disclosed Long-Term Investments across 8 years of filings, most recently posting $1.6 million for Q4 2025.
- In Q4 2025, Long-Term Investments rose 28.39% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 28.39% YoY), while the FY2025 annual figure was $1.4 million, up 36.88% from the prior year.
- Long-Term Investments came in at $1.6 million for Q4 2025 at Mesoblast, up from $1.4 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.3 million in Q4 2021 to a low of $826000.0 in Q4 2023.
- Average Long-Term Investments over 5 years is $1.7 million, with a median of $1.8 million recorded in 2022.
- Year-over-year, Long-Term Investments slumped 57.62% in 2023 and surged 46.25% in 2024.
- Over 5 years, Long-Term Investments stood at $2.3 million in 2021, then decreased by 16.96% to $1.9 million in 2022, then tumbled by 57.62% to $826000.0 in 2023, then jumped by 46.25% to $1.2 million in 2024, then rose by 28.39% to $1.6 million in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $1.6 million in Q4 2025, $1.4 million in Q2 2025, and $1.2 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 257.29 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 30.27 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 490,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 362.70 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 102.10 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Dec 31, 2023 | 826,000.00 |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Sep 30, 2021 | 2.23 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | 1.87 Mn |
| Mar 31, 2020 | 1.77 Mn |
| Dec 31, 2019 | 1.67 Mn |